// App-Quantinova.ai

DOP11 : Lymphocyte activation gene (LAG)-3 on T cells is a potential therapeutic target in ulcerative colitis

Researchers

Presenter

  • S Slevin

Principal Investigators

  • M Tan

  • C Lahiff

  • L M Wang

  • B Greenaway

  • K Lynch

  • A Geremia

  • S Hughes

  • K Leavens

  • K Nevin

  • D J B Marks

  • R Tarzi

  • N Srinivasan

  • S Travis

  • C Arancibia

  • S Keshav

Medical Centers

  • University of Oxford, Translational Gastroenterology, Oxford, United Kingdom

  • Changi General Hospital, SingHealth, Department of Laboratory Medicine, Singapore, Singapore

  • GlaxoSmithKline, Experimental Medicine Unit, Stevenage, UK

Locations

  • United Kingdom

  • Singapore

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Ulcerative colitis

Biomarkers

  • Cytokine

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved